Skip to main content

Oregon State Flag An official website of the State of Oregon »

Oregon.gov Homepage

Prescription Drug Affordability Board (PDAB)

  • DPT drug price hearing is Dec. 4

    The Drug Price Transparency Program (DPT) will host its annual hearing on Wednesday, Dec. 4, at 10:00 a.m. The hearing will be held in person at 350 Winter St. NE, Salem, and also online. The agenda features panel discussions about drug advertising and drug rebates, along with an overview of the 2024 Drug Price Transparency report to the Oregon Legislature. Learn more on the DPT website and find the link to join the hearing online.


    • 2024 Generic Drug Report

    The Prescription Drug Affordability Board's annual generic drug report is now available on the PDAB website. The board approved the report at the May 15 meeting. The report discusses authorized generics, generic and biosimilar litigation, legislation, pricing, and substitutions, generic formulary placement, drug shortages and generics in other countries. Find the report posted on the Legislative Reports web page.

    About the PDAB

    The Prescription Drug Affordability Board is established in the Department of Consumer and Business Services under ORS 646A.693 to protect residents of Oregon, state and local governments, commercial health plans, health care providers, pharmacies licensed in Oregon and others within the health care system in this state from the high costs of prescription drugs. To learn more about the board’s work, see the FAQ page.